Pure Global
NCT06373666

A Study to Evaluate the Adjustment Function of a Modified Spatz3 Adjustable Balloon (Spatz4).

Spatz FGIA, Inc·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Overweight and Obesity
Drug/Device/Intervention
Spatz4 Adjustable Balloon System
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Spatz FGIA, Inc
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Jun 01, 2025
Enrollment
20 participants
Primary outcome

Successful adjustment procedure at 16 ±2 weeks in 85% of attempts.

Summary

The purpose of this study is to evaluate the function of the adjustment procedure with the
 Spatz4 in subjects with a BMI ≥ 27.

ICD-10 classifications
ObesityOther obesityObesity due to excess caloriesObesity, unspecifiedObesity and other hyperalimentation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06373666
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06373666 through Pure Global AI's free database. This phase not specified trial is sponsored by Spatz FGIA, Inc and is currently Not yet recruiting. The study focuses on Overweight and Obesity. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.